Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC), 41447 [E9-19698]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 157 / Monday, August 17, 2009 / Notices
mstockstill on DSKH9S0YB1PROD with NOTICES
Control and Prevention, announces the
following meeting for the
aforementioned subcommittee:
Time and Date: 10 a.m.–5 p.m., September
3, 2009.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018.
Telephone (859) 334–4611, Fax (859) 334–
4619.
Status: Open to the public, but without a
public comment period. To access by
conference call dial the following
information 1(866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2011.
Purpose: The Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for
the Subcommittee meeting includes:
Discussion of dose reconstruction cases
under review; OCAS dose reconstruction
quality management and assurance activities;
selection of an additional set of cases for
review.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
VerDate Nov<24>2008
17:55 Aug 14, 2009
Jkt 217001
the contact person below well in advance of
the meeting.
For More Information Contact: Theodore
Katz, Executive Secretary, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta GA
30333, Telephone (513) 533–6800, Toll Free
1(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–19701 Filed 8–14–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (ACD, CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Meeting of the
aforementioned committee:
Time and Date: 4:30 p.m.–6 p.m.,
September 1, 2009.
Place: The teleconference call will
originate at the Centers for Disease Control
and Prevention in Atlanta, Georgia. Please
see Supplementary Information for details on
accessing the teleconference.
Status: Open to the public, teleconference
access limited only by availability of
telephone ports.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters To Be Discussed: The committee
will discuss and decide on recommendations
from its Ethics Subcommittee, National
Biosurveillance Advisory Subcommittee, and
the Health Disparities Subcommittee. The
Ethics Subcommittee will make
recommendations on using travel restrictions
for individuals with infectious illnesses; and
discuss a draft charge that clearly articulates
the ethical foundation for focusing on health
protection activities and examining the social
determinants of health. The National
Biosurveillance Advisory Subcommittee will
present their final report on biosurveillance
recommendations. The Health Disparities
Subcommittee will present their mission.
The ACD, CDC will also receive an update on
H1N1 and the plans for the upcoming flu
season.
Agenda items are subject to change as
priorities dictate.
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
41447
Supplementary Information: This
conference call is scheduled to begin at 4:30
p.m. To participate in the teleconference,
please dial 1–800–593–9961 and enter
conference code 3699611. You will then be
automatically connected to the call.
Contact Person for More Information: Anne
Haddix, M.D., Designated Federal Officer,
Advisory Committee to the Director, CDC,
1600 Clifton Road, NE., M/S D–14, Atlanta,
Georgia 30333. Telephone 404–639–0663.
The Director, Management Analysis and
Services office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. E9–19698 Filed 8–14–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities; NACMHD
Date: September 8, 2009
Closed: 8 a.m. to 10 a.m.
E:\FR\FM\17AUN1.SGM
17AUN1
]]>Agencies
[Federal Register Volume 74, Number 157 (Monday, August 17, 2009)]
[Notices]
[Page 41447]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19698]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director, Centers for Disease Control
and Prevention (ACD, CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Meeting of the aforementioned
committee:
Time and Date: 4:30 p.m.-6 p.m., September 1, 2009.
Place: The teleconference call will originate at the Centers for
Disease Control and Prevention in Atlanta, Georgia. Please see
Supplementary Information for details on accessing the
teleconference.
Status: Open to the public, teleconference access limited only
by availability of telephone ports.
Purpose: The committee will provide advice to the CDC Director
on strategic and other broad issues facing CDC.
Matters To Be Discussed: The committee will discuss and decide
on recommendations from its Ethics Subcommittee, National
Biosurveillance Advisory Subcommittee, and the Health Disparities
Subcommittee. The Ethics Subcommittee will make recommendations on
using travel restrictions for individuals with infectious illnesses;
and discuss a draft charge that clearly articulates the ethical
foundation for focusing on health protection activities and
examining the social determinants of health. The National
Biosurveillance Advisory Subcommittee will present their final
report on biosurveillance recommendations. The Health Disparities
Subcommittee will present their mission. The ACD, CDC will also
receive an update on H1N1 and the plans for the upcoming flu season.
Agenda items are subject to change as priorities dictate.
Supplementary Information: This conference call is scheduled to
begin at 4:30 p.m. To participate in the teleconference, please dial
1-800-593-9961 and enter conference code 3699611. You will then be
automatically connected to the call.
Contact Person for More Information: Anne Haddix, M.D.,
Designated Federal Officer, Advisory Committee to the Director, CDC,
1600 Clifton Road, NE., M/S D-14, Atlanta, Georgia 30333. Telephone
404-639-0663.
The Director, Management Analysis and Services office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: August 10, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. E9-19698 Filed 8-14-09; 8:45 am]
BILLING CODE 4163-18-P
